Long-term Pre-dialysis Extension in Europe and Asia Pacific
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 166 participants.
Also called NCT02055482
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 166 participants
- Sponsor
- Registry
-
NCT02055482 -
2013-001190-24
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Bulgaria, France, Germany, Hungary, Israel, Italy, Japan, Poland, Romania, South Korea, Spain, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02055482. Randomized; no masking; primary purpose treatment. Start 2014-06-24 (actual); primary completion 2016-11-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Long-term Pre-dialysis Extension in Europe and Asia Pacific
- Acronym
- DIALOGUE 3
- Condition
- Anemia
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- Molidustat (BAY85-3934)
- Intervention (Biological)
- Darbepoetin
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct02055482- Content hash
09c2ecf01f4be23966d474e10251cf5fbf2bd15c4719323f40f8ff6bf9465f57